MedTrace Logo

ED Management of Severe Hyperglycemia: A Clinical Trial

NCT02478190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2018-03-21

No results posted yet for this study

Summary

Emergency Department (ED) patients with severe hyperglycemia will be randomized to two treatment goals: discharge glucose less than 600 mg/dL or less than 350 mg/dL.

Randomization is stratified by whether the chief complaint is "High Blood Sugar" in the electronic medical record or other.

Conditions

Interventions

OTHER

Tight control: goal glucose 350 mg/dL or lower

Goal glucose at discharge will be 350 mg/dL or less.

OTHER

Loose control: goal glucose 600 mg/dL or lower

Goal glucose at discharge will be 600 mg/dL or less.

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Brian Driver, MD · HCMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02478190 on ClinicalTrials.gov